Literature DB >> 18339633

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.

Dilip Nathwani1, Marina Morgan, Robert G Masterton, Matthew Dryden, Barry D Cookson, Gary French, Deirdre Lewis.   

Abstract

These guidelines have been developed by a Working Party convened on behalf of the British Society for Antimicrobial Chemotherapy. Their aim is to provide general practitioners and other community- and hospital-based healthcare professionals with pragmatic advice about when to suspect MRSA infection in the community, when and what cultures should be performed and what should be the management options, including the need for hospitalization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339633     DOI: 10.1093/jac/dkn096

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  58 in total

1.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

Review 3.  MRSA: treating people with infection.

Authors:  Nikolas Rae; Anna Jarchow-MacDonald; Dilip Nathwani; Charis Ann Marwick
Journal:  BMJ Clin Evid       Date:  2016-02-16

4.  Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.

Authors:  R A Seaton; S Johal; J E Coia; N Reid; S Cooper; B L Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-31       Impact factor: 3.267

Review 5.  Antibacterial Antifolates: From Development through Resistance to the Next Generation.

Authors:  Alexavier Estrada; Dennis L Wright; Amy C Anderson
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

6.  Are you taking the lead?

Authors:  Jon S Friedland
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

7.  Clinical application of real-time PCR to screening critically ill and emergency-care surgical patients for methicillin-resistant Staphylococcus aureus: a quantitative analytical study.

Authors:  M Trent Herdman; Duncan Wyncoll; Eugene Halligan; Penelope R Cliff; Gary French; Jonathan D Edgeworth
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 8.  MRSA: treating people with infection.

Authors:  Dilip Nathwani; Peter Garnet Davey; Charis Ann Marwick
Journal:  BMJ Clin Evid       Date:  2010-10-28

Review 9.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

10.  Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Authors:  Binh An Diep; Anna Afasizheva; Hoan N Le; Osamu Kajikawa; Gustavo Matute-Bello; Christine Tkaczyk; Bret Sellman; Cedric Badiou; Gerard Lina; Henry F Chambers
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.